| 摘要 |
The cyclic ureas, and the pharmaceutically-acceptable salts and esters thereof, of the present invention are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: <IMAGE> wherein X, Y, A, L, R, R1, R2, R3, R4, and R5 are defined as in the Specification.
|
